Detalhe da pesquisa
1.
Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study.
Hum Vaccin Immunother
; 18(1): 1-10, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085900
2.
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial.
Lancet Infect Dis
; 21(2): 252-262, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946836
3.
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial.
NPJ Vaccines
; 3: 34, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30210819
4.
The development and clinical evaluation of second-generation leishmaniasis vaccines.
Vaccine
; 30(2): 134-41, 2012 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22085553
5.
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis.
Vaccine
; 29(19): 3531-7, 2011 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21414377
6.
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis.
Vaccine
; 28(40): 6581-7, 2010 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20688040
7.
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis.
Vaccine
; 28(46): 7427-35, 2010 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20851080
8.
Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis.
Vaccine
; 28(2): 329-37, 2009 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19879995
9.
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.
J Pediatr
; 143(4): 532-40, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14571236
10.
Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.
J Infect Dis
; 190(5): 975-8, 2004 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15295704